These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 19301459)

  • 1. IL-2 therapy provides no clinical benefit to HIV-infected patients on ART.
    Clin Infect Dis; 2009 Apr; 48(8):iii. PubMed ID: 19301459
    [No Abstract]   [Full Text] [Related]  

  • 2. Study on CD4 cell responses in HIV infected subjects in Nepal.
    Tiwari BR; Ghimire P; Malla S
    Nepal Med Coll J; 2008 Mar; 10(1):45-7. PubMed ID: 18700632
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Definitive results: IL-2 does not benefit HIV-infected patients. Interleukin-2 improves CD4-cell recovery in patients on antiretroviral therapy, but that benefit does not translate into lower risks for disease or death.
    Hicks CB
    J Watch AIDS Clin Care; 2010 Jan; 22(1):4. PubMed ID: 20617576
    [No Abstract]   [Full Text] [Related]  

  • 4. Antiretroviral Service to HIV patients of low CD4 count in Seti Zonal Hospital.
    Paudel BN; Chaudhary SR; Sharma S; Dhungana GP; Paudel P
    JNMA J Nepal Med Assoc; 2009; 48(173):24-7. PubMed ID: 19529054
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interleukin-2 before antiretroviral therapy in patients with HIV infection: a randomized trial (ANRS 119).
    Molina JM; Levy Y; Fournier I; Hamonic S; Bentata M; Beck-Wirth G; Gougeon ML; Venet A; Madelaine I; Sereni D; Jeanblanc F; Boulet T; Simon F; Aboulker JP;
    J Infect Dis; 2009 Jul; 200(2):206-15. PubMed ID: 19508157
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost-effectiveness of strategies for monitoring the response to antiretroviral therapy in resource-limited settings.
    Phillips AN; Gilks C; Lundgren JD
    Arch Intern Med; 2009 May; 169(9):904; author reply 904-5. PubMed ID: 19433706
    [No Abstract]   [Full Text] [Related]  

  • 7. HIV doctors may treat all infected, adding thousands.
    AIDS Read; 2008 Dec; 18(12):592-3. PubMed ID: 19123254
    [No Abstract]   [Full Text] [Related]  

  • 8. Total lymphocyte count: a surrogate marker for predicting CD4+ count in enrolled process for antiretroviral therapy in resource-limited settings.
    Susaengrat W; Mitchai M; Leerattanapetch N
    J Med Assoc Thai; 2008 Oct; 91(10):1514-7. PubMed ID: 18972893
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Simple methods on supporting ARV therapy services.
    Djauzi S
    Acta Med Indones; 2008 Apr; 40(2):53-4. PubMed ID: 19054880
    [No Abstract]   [Full Text] [Related]  

  • 10. Editorial comment: predictors of response--updating the traditional list.
    Gallant JE
    AIDS Read; 2006 Aug; 16(8):432-3. PubMed ID: 16933377
    [No Abstract]   [Full Text] [Related]  

  • 11. Interleukin-2 therapy in patients with HIV infection.
    Sellier P; Lafuente-Lafuente C; Bergmann JF
    N Engl J Med; 2010 Jan; 362(3):270-1; author reply 271. PubMed ID: 20089981
    [No Abstract]   [Full Text] [Related]  

  • 12. Early initiation of ART produces better clinical outcomes.
    Clin Infect Dis; 2009 Apr; 48(8):iii. PubMed ID: 19301458
    [No Abstract]   [Full Text] [Related]  

  • 13. HAART and IL-2.
    AIDS Patient Care STDS; 2001 Jan; 15(1):54. PubMed ID: 11265652
    [No Abstract]   [Full Text] [Related]  

  • 14. Clinical practice. Management of newly diagnosed HIV infection.
    Hammer SM
    N Engl J Med; 2005 Oct; 353(16):1702-10. PubMed ID: 16236741
    [No Abstract]   [Full Text] [Related]  

  • 15. Interleukin-2: trials and tribulations.
    Kuritzkes DR
    J Infect Dis; 2009 Jul; 200(2):164-5. PubMed ID: 19508158
    [No Abstract]   [Full Text] [Related]  

  • 16. A national survey of prisoners on antiretroviral therapy in Malawi: access to treatment and outcomes on therapy.
    Makombe SD; Jahn A; Tweya H; Thambo L; Yu JK; Hedt B; Weigel R; Nkhata A; Schouten EJ; Kamoto K; Harries AD
    J Infect Dev Ctries; 2007 Dec; 1(3):303-7. PubMed ID: 19734609
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnosis of antiretroviral therapy failure in Malawi: poor performance of clinical and immunological WHO criteria.
    van Oosterhout JJ; Brown L; Weigel R; Kumwenda JJ; Mzinganjira D; Saukila N; Mhango B; Hartung T; Phiri S; Hosseinipour MC
    Trop Med Int Health; 2009 Aug; 14(8):856-61. PubMed ID: 19552661
    [TBL] [Abstract][Full Text] [Related]  

  • 18. "Absolute" or "added" predictive value?
    Koole O; Van den Ende J
    Trop Med Int Health; 2010 Mar; 15(3):382; author reply 382-4. PubMed ID: 20074084
    [No Abstract]   [Full Text] [Related]  

  • 19. Effect of HIV viral load, CD4 cell count and antiretroviral therapy on human papillomavirus prevalence in urine samples of HIV-infected men.
    Jong E; van Gorp EC; Mulder JW; Tol A; Smits PH
    Int J STD AIDS; 2009 Apr; 20(4):262-4. PubMed ID: 19304972
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increasing CD4 count with interleukin-2 does not benefit people with HIV.
    Roehr B
    BMJ; 2009 Feb; 338():b615. PubMed ID: 19218320
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.